Barbara Melotti

1.6k total citations
69 papers, 826 citations indexed

About

Barbara Melotti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Barbara Melotti has authored 69 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Barbara Melotti's work include Lung Cancer Treatments and Mutations (18 papers), Cutaneous Melanoma Detection and Management (14 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Barbara Melotti is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Cutaneous Melanoma Detection and Management (14 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Barbara Melotti collaborates with scholars based in Italy, France and United States. Barbara Melotti's co-authors include Francesca Sperandi, Andrea Ardizzoni, Francesco Gelsomino, Emi Dika, Annalisa Patrizi, F Pannuti, M. Guaraldi, Andrea Martoni, Martina Lambertini and Michelangelo Fiorentino and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Barbara Melotti

63 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Melotti Italy	17	502	263	182	84	79	69	826
Giovanni Pietro Ianniello Italy	15	615 1.2×	494 1.9×	123 0.7×	72 0.9×	58 0.7×	37	987
Isabella C. Glitza United States	19	579 1.2×	319 1.2×	255 1.4×	78 0.9×	55 0.7×	46	953
M Lucchesi Italy	13	210 0.4×	135 0.5×	120 0.7×	80 1.0×	37 0.5×	70	574
Anna Compagnoni Italy	13	351 0.7×	207 0.8×	180 1.0×	109 1.3×	21 0.3×	19	840
Hüseyin Abalı Türkiye	16	240 0.5×	182 0.7×	76 0.4×	49 0.6×	55 0.7×	62	669
Wanqing Iris Zhi United States	16	585 1.2×	221 0.8×	263 1.4×	29 0.3×	45 0.6×	40	1.2k
Gülten Tekuzman Türkiye	15	334 0.7×	171 0.7×	111 0.6×	55 0.7×	57 0.7×	58	737
Rebecca J. McClaine United States	13	240 0.5×	116 0.4×	159 0.9×	58 0.7×	24 0.3×	17	558
Yiming Luo United States	11	160 0.3×	110 0.4×	99 0.5×	57 0.7×	33 0.4×	30	773
Sofia Baka Greece	20	471 0.9×	640 2.4×	222 1.2×	90 1.1×	19 0.2×	71	1.2k

Countries citing papers authored by Barbara Melotti

Since Specialization

Citations

This map shows the geographic impact of Barbara Melotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Melotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Melotti more than expected).

Fields of papers citing papers by Barbara Melotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Melotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Melotti. The network helps show where Barbara Melotti may publish in the future.

Co-authorship network of co-authors of Barbara Melotti

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Melotti. A scholar is included among the top collaborators of Barbara Melotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Melotti. Barbara Melotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Federico, Alessandro Di, et al.. (2025). Efficacy and Safety of TROP-2-Targeting Antibody–Drug Conjugate Treatment in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Pooled Analysis of Reconstructed Patient Data. Cancers. 17(11). 1750–1750. 1 indexed citations

Broseghini, Elisabetta, Costantino Ricci, Barbara Corti, et al.. (2025). Merkel Cell Carcinoma: An Updated Review Focused on Bone and Bone Marrow Metastases. Cancers. 17(13). 2253–2253.

Giglio, Andrea De, Maria Conte, Serena De Matteis, et al.. (2025). P2.06.92 Host-Derived Biomarkers of Inflammation and Body Composition Predict Immunotherapy Outcomes in Advanced NSCLC. Journal of Thoracic Oncology. 20(10). S334–S335.

Giglio, Andrea De, Giulia Venturi, Alessandro Di Federico, et al.. (2024). Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report. SHILAP Revista de lepidopterología. 6. 100161–100161. 3 indexed citations

Federico, Alessandro Di, Hugo de Jonge, Andrea De Giglio, et al.. (2024). Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations. JCO Precision Oncology. 8(8). e2400240–e2400240. 2 indexed citations

Maloberti, Thais, Antonio De Leo, Elisa Gruppioni, et al.. (2024). Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel. Diagnostics. 14(8). 800–800. 3 indexed citations

Giglio, Andrea De, Dario de Biase, Thais Maloberti, et al.. (2024). STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status. Lung Cancer. 199. 108058–108058. 3 indexed citations

Casadio, Chiara, Andrea De Giglio, Barbara Melotti, et al.. (2024). A new classification of upper gastrointestinal toxicity induced by immunotherapy: from endoscopic and pathological insights to clinical management. SHILAP Revista de lepidopterología. 5. 100083–100083.

Comito, Francesca, et al.. (2023). Retreatment with sonidegib in a patient with multiple basal cell carcinomas and multiple comorbidities: a complex real-life scenario. Italian Journal of Dermatology and Venereology. 158(2). 150–152. 1 indexed citations

10.

Federico, Alessandro Di, Andrea De Giglio, Francesco Gelsomino, et al.. (2022). Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes. Cancers. 14(14). 3472–3472. 10 indexed citations

11.

Dika, Emi, Martina Lambertini, Emanuela Marcelli, et al.. (2021). Oral Manifestations in Melanoma Patients Treated with Target or Immunomodulatory Therapies. Journal of Clinical Medicine. 10(6). 1283–1283. 9 indexed citations

12.

Ricci, Costantino, Francesca Ambrosi, Marco Grillini, et al.. (2020). Next‐generation sequencing revealing TP53 mutation as potential genetic driver in dermal deep‐seated melanoma arising in giant congenital nevus in adult patients: A unique case report and review of the literature. Journal of Cutaneous Pathology. 47(12). 1164–1169. 5 indexed citations

13.

Dika, Emi, Martina Lambertini, Píer Alessandro Fanti, et al.. (2019). Sequential monitoring of pigmented lesions during dabrafenib treatment: a prospective study and a literature overview. Giornale Italiano di Dermatologia e Venereologia. 154(2). 170–176. 1 indexed citations

14.

Ghedini, Pietro, Irene Bossert, Lucia Zanoni, et al.. (2017). Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis. European Journal of Nuclear Medicine and Molecular Imaging. 45(5). 751–758. 9 indexed citations

15.

Gelsomino, Francesco, Alessandro Leonetti, Karim Rihawi, et al.. (2017). Immune checkpoint inhibition in small cell lung cancer: a key to reach an unmet need?. Translational Cancer Research. 6. 2 indexed citations

16.

Migliorino, M.R., Alain Gelibter, Francesco Grossi, et al.. (2017). Use of nivolumab in elderly patients with advanced non-squamous NSCLC: Results from the Italian expanded access program (EAP). Annals of Oncology. 28. v471–v471. 6 indexed citations

17.

Gelsomino, Francesco, Michelangelo Fiorentino, Maurizio Zompatori, et al.. (2017). Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques?. Annals of Oncology. 29(1). 284–286. 24 indexed citations

18.

Gelsomino, Francesco, Valentina Ambrosini, Barbara Melotti, Francesca Sperandi, & Andrea Ardizzoni. (2016). Pitfalls in Oncology: Osteoblastic Response Mimicking Bone Progression during Ceritinib Treatment in ALK -Rearranged NSCLC. Journal of Thoracic Oncology. 11(8). e99–e101. 4 indexed citations

19.

Bandieri, Elena, Marilena Romero, Carla Ripamonti, et al.. (2015). Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain. Journal of Clinical Oncology. 34(5). 436–442. 96 indexed citations

20.

Martoni, Andrea, et al.. (1993). A Phase II Study of Carboplatin and Cyclophosphamide in Advanced Ovarian Carcinoma. Journal of Chemotherapy. 5(1). 47–51. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact